Product Information
SIROLIMUS 0.5 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $1.1138 per EA under NDC 67877074601. Its NADAC has been published 264 times since Jun 9, 2021.
Strength
.5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877074601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA214753On Market Since
3/13/2021
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 0.5 MG TABLET has been published 264 times since Jun 9, 2021, and over the history we have for it it has declined 81.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1138 per EA |
|---|---|
| All-time high | $5.9175 (Jun 16, 2021) |
| All-time low | $1.0918 (May 20, 2026) |
| 52-week high | $2.3742 |
| 52-week low | $1.0918 |
| Median price | $2.6973 |
| Average price | $3.1751 |
| Largest weekly change | -50.5% (Sep 20, 2023) |
| Weeks tracked | 264 |
| Tracking since | Jun 9, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Sirolimus market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SIROLIMUS 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 0.5 MG TABLET, manufactured by Ascend Laboratories, LLC, is $1.1138 per EA (NDC 67877074601), effective Jun 24, 2026.
How has the price of SIROLIMUS 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 0.5 MG TABLET has declined 81.2%. It has been tracked across 264 weekly CMS publications since Jun 9, 2021.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 0.5 MG TABLET?
Since Jun 9, 2021, the NADAC for SIROLIMUS 0.5 MG TABLET has ranged from a low of $1.0918 (May 20, 2026) to a high of $5.9175 (Jun 16, 2021), with a median of $2.6973 per EA.
Are there cheaper alternatives to SIROLIMUS 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SIROLIMUS 0.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures SIROLIMUS 0.5 MG TABLET?
SIROLIMUS 0.5 MG TABLET (NDC 67877074601) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification